rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
5
|
pubmed:dateCreated |
1998-1-8
|
pubmed:abstractText |
Pneumocystis carinii pneumonia (PCP) is an important cause of acute respiratory failure in HIV-infected children. PCP may initiate acute respiratory distress syndrome (ARDS) by adversely affecting surfactant physiology. We report improved pulmonary function following administration of bovine lipid extract surfactant to two infants with AIDS-related PCP/ARDS.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
8755-6863
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
24
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
370-3
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:9407571-AIDS-Related Opportunistic Infections,
pubmed-meshheading:9407571-Animals,
pubmed-meshheading:9407571-Blood Gas Analysis,
pubmed-meshheading:9407571-Cattle,
pubmed-meshheading:9407571-Fatal Outcome,
pubmed-meshheading:9407571-Female,
pubmed-meshheading:9407571-Humans,
pubmed-meshheading:9407571-Infant,
pubmed-meshheading:9407571-Infant, Newborn,
pubmed-meshheading:9407571-Male,
pubmed-meshheading:9407571-Pneumonia, Pneumocystis,
pubmed-meshheading:9407571-Pulmonary Gas Exchange,
pubmed-meshheading:9407571-Pulmonary Surfactants,
pubmed-meshheading:9407571-Respiratory Distress Syndrome, Newborn
|
pubmed:year |
1997
|
pubmed:articleTitle |
Surfactant therapy improves pulmonary function in infants with Pneumocystis carinii pneumonia and acquired immunodeficiency syndrome.
|
pubmed:affiliation |
Department of Pediatrics, University of Ottawa, Ontario, Canada.
|
pubmed:publicationType |
Journal Article,
Case Reports,
Research Support, Non-U.S. Gov't
|